Patient-Centered Precision Health In A Learning Health Care System: Geisinger’s Genomic Medicine Experience
Palmer Commons - Great Lakes North Central
Palmer Commons - Great Lakes North Central
Medicine in the 21st century is being increasingly influenced by two concepts: Precision Medicine and the Learning Healthcare System. To broadly realize the promise of precision medicine (and health), it is necessary to use frameworks of implementation science grounded in the philosophy of the learning healthcare system to achieve robust implementation and value. This presentation will describe the implementation of a precision health program in an integrated healthcare delivery system aspiring to become a learning healthcare system. It will include early outcomes for the CDC Tier 1 genomic medicine conditions that identify significant care gaps and opportunities for improvement. LHS Collaboratory and U-M Precision Health

Patient-Centered Precision Health In A Learning Health Care System: Geisinger’s Genomic Medicine Experience

Marc Williams, MD, is the Director of Geisinger’s Genomic Medicine Institute and will describe the implementation of a precision health program in an integrated healthcare delivery system.

icon to add this event to your google calendarNovember 29, 2018
12:00 pm - 1:30 pm
Palmer Commons - Great Lakes North Central
Sponsored by: LHS Collaboratory and U-M Precision Health
Contact Information: Cindy Diakow - cdiakow@med.umich.edu

More Information & Registration

Medicine in the 21st century is being increasingly influenced by two concepts: Precision Medicine and the Learning Healthcare System. To broadly realize the promise of precision medicine (and health), it is necessary to use frameworks of implementation science grounded in the philosophy of the learning healthcare system to achieve robust implementation and value. This presentation will describe the implementation of a precision health program in an integrated healthcare delivery system aspiring to become a learning healthcare system. It will include early outcomes for the CDC Tier 1 genomic medicine conditions that identify significant care gaps and opportunities for improvement.